Research and Publication Ethics

The journal adheres completely to the ethical guidelines for research and publication described in Guidelines on Good Publication (http://publicationethics.org/resources/guidelines), the ICMJE Guidelines (http://www.icmje.org), and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice).

1. Authorship

Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; 2) drafting the article or reviewing it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Corresponding author and first author: International Journal of Gastrointestinal Intervention (IJGII) does not allow multiple corresponding authors for one article. Only one author should correspond with the editorial office and readers for one article. IJGII does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors.
Correction of authorship after publication: IJGII does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.

2. Originality, Plagiarism, and Duplicate Publication

Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board. Submitted manuscripts are screened for possible plagiarism or duplicate publication by Similarity Check upon arrival. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed. There will also be penalties for the authors.
A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.

3. Secondary Publication

Compliance with ICMJE Recommendations: The journal adheres completely to the ethical guidelines for research and publication described in Guidelines on Good Publication (http://publicationethics.org/resources/guidelines), the ICMJE Guidelines (http://www.icmje.org), and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice). Furthermore, all process of dealing research and publication misconduct shall be followed by Flow chart of COPE (http://publicationethics.org/resources/flowcharts).

4. Conflict of Interest Statement

The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of the data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. Conflict of interest statements will be published at the end of the text of the article, before the ‘References’ section. Please consult the COPE guidelines (http://www.publicationethics.org/) on conflict of interest. Even when there is no conflict of interest, it should also be stated.

Policy for submissions by members of the editorial team
As all editors and Editorial Board members at the IJGII are active professionals and researchers, it may happen that they would want to submit their articles to the IJGII. This represents a potential conflict of interest, especially in cases of submissions from decision-making editors. In reviewing submissions from its editors and Editorial Board members, the IJGII follows the guidelines for good editorial practice set by international editorial organizations, such as World Association of Medical Editors (WAME; http://www.wame.org/resources/publication-ethics-policies-for-medicaljournals#conflicts) and Committee on Publication Ethics (COPE; https://publicationethics.org/case/editor-author-own-journal). The review of such manuscripts will not be handled by the submitting editor(s); the review process will be supervised and decisions made by a senior editor who will act independently of other editors. In some cases, the review process will be handled by an outside independent expert to minimize possible bias in reviewing submissions from editors.
Also, conflict of interest statement should be included in on the title page, as the following examples. AAA has been an editor (Editor-in-Chief) of the International Journal of Gastrointestinal Intervention (IJGII) since 20XX; however, AAA has not been involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

5. Statement of Human and Animal Right

Clinical research should be done in accordance of the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Helsinki Declaration of 1975 (revised 2013), available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects should not be identifiable, such that patients' names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.

6. Statement of Informed Consent and Institutional Review Board Approval

Copies of written informed consent documents should be kept for studies on human subjects. For clinical studies of human subjects, a certificate, agreement, or approval by the Institutional Review Board (IRB) of the author’s institution is required. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct.

7. Process for Managing Research and Publication Misconduct

When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.

8. Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern

Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from: http://publicationethics.org/resources/flowcharts. If correction needs, it will follow the ICMJE Recommendation for Corrections, Retractions, Republications and Version Control available from:
https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html as follows:

Honest errors are a part of science and publishing and require publication of a correction when they are detected. Corrections are needed for errors of fact. Minimum standards are as follows: First, it shall publish a correction notice as soon as possible detailing changes from and citing the original publication on both an electronic and numbered print page that is included in an electronic or a print Table of Contents to ensure proper indexing; Second, it shall post a new article version with details of the changes from the original version and the date(s) on which the changes were made through CrossMark; Third, it shall archive all prior versions of the article. This archive can be either directly accessible to readers; and Fourth, previous electronic versions shall prominently note that there are more recent versions of the article via CrossMark.

9. Editorial Responsibilities

The Editorial Board will continuously work to monitor and safeguard publication ethics: guidelines for retracting articles; maintenance of the integrity of the academic record; preclusion of business needs from compromising intellectual and ethical standards; publishing corrections, clarifications, retractions, and apologies when needed; and excluding plagiarism and fraudulent data. The editors maintain the following responsibilities: responsibility and authority to reject and accept articles; avoiding any conflict of interest with respect to articles they reject or accept; promoting publication of corrections or retractions when errors are found; and preservation of the anonymity of reviewers.

10. Research Ethics Committee and Role of the Committee

• 1) The Journal operates a Research Ethics Committee (the Committee hereafter) for consideration of research ethics and related issues.
  • (1) Chairperson of the publication committee of the Society of Gastrointestinal Intervention (SGI) is the chair of the Committee. The constitution of the Committee is decided by the publication committee of SGI.
  • (2) Operation of the Committee follows separate regulations decided by the Committee.

• 2) The roles of the Committee are as follows.
  • (1) The Committee reviews research ethics issued from the publication of the Journal and related papers (Original articles, Case reports, Review articles and others).
  • (2) The Committee reviews any fabrication, falsification of data, originality and plagiarism, material failure to comply with legislative and regulatory requirements affecting research, wrongful research paper author indication, or multiple or duplicates publication allegations for published papers and brings the results to the executive committee of SGI.

11. Administration of Research Ethics Violation

When research ethics violations occur, the Committee decides a disciplinary measure. The Committee should call a meeting immediately to review the situation and report the results to the executive committee of SGI.

• (1) If duplicate or divided publication or any other ethical violation was confirmed, manuscripts even if already published will be retracted with a notice published in the next issue, as well as to related academic institutions.
• (2) The Committee keeps a record of the investigation and the results of ethical misconduct.
• (3) Author who violates this policy or general ethics can be prohibited publication to IJGII for a specified time.
• (4) The Journal follows the Code of Conduct (http://publicationethics.org/resources/code-conduct) of the Committee on Publication Ethics (COPE) (http://publicationethics.org/), and follows the COPE Flowcharts (http://publicationethics.org/resources/flowcharts) for resolving cases of suspected misconduct